dabrafenib 50 MG Oral Capsule [Tafinlar]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

dabrafenib 50 MG Oral Capsule [Tafinlar]

50 MG · Oral Capsule · oral

A form of dabrafenib →

dabrafenib 50 MG Oral Capsule [Tafinlar] — B-Raf serine-threonine kinase (BRAF) inhibitors. Strength, form, class, interactions & more.

dabrafenib 50 MG Oral Capsule [Tafinlar]

Active ingredient

Classification

B-Raf serine-threonine kinase (BRAF) inhibitorsKinase Inhibitor

Drug interactions

Dabrafenib has several interactions with drugs that are substrates of CYP enzymes, particularly CYP3A4 and CYP2C8.

  • majorstrong inhibitors of CYP3A4 or CYP2C8 — may increase the concentration of dabrafenib
  • moderatemidazolam — decreased systemic exposures
  • moderateS-warfarin — decreased systemic exposures
  • moderateR-warfarin — decreased systemic exposures
  • moderatedexamethasone — decreased concentrations and loss of efficacy
  • moderatehormonal contraceptives — decreased concentrations and loss of efficacy

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.